| Product Code: ETC6736433 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Angiogenesis Inhibitors Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Angiogenesis Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 China Angiogenesis Inhibitors Market - Industry Life Cycle |
3.4 China Angiogenesis Inhibitors Market - Porter's Five Forces |
3.5 China Angiogenesis Inhibitors Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 China Angiogenesis Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 China Angiogenesis Inhibitors Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 China Angiogenesis Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 China Angiogenesis Inhibitors Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 China Angiogenesis Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Angiogenesis Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in China |
4.2.2 Growing demand for targeted cancer therapies |
4.2.3 Rising healthcare expenditure in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High cost associated with angiogenesis inhibitors |
4.3.3 Limited access to advanced healthcare facilities in rural areas |
5 China Angiogenesis Inhibitors Market Trends |
6 China Angiogenesis Inhibitors Market, By Types |
6.1 China Angiogenesis Inhibitors Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 China Angiogenesis Inhibitors Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 China Angiogenesis Inhibitors Market Revenues & Volume, By VEGF Targeted Therapy, 2021- 2031F |
6.1.4 China Angiogenesis Inhibitors Market Revenues & Volume, By FGF Targeted Therapies, 2021- 2031F |
6.1.5 China Angiogenesis Inhibitors Market Revenues & Volume, By Oncogene Targeted Therapy, 2021- 2031F |
6.1.6 China Angiogenesis Inhibitors Market Revenues & Volume, By Matrix Degrading and Remodeling Targeted Therapy, 2021- 2031F |
6.1.7 China Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Angiogenesis Inhibitors Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 China Angiogenesis Inhibitors Market Revenues & Volume, By Glioblastoma, 2021- 2031F |
6.2.3 China Angiogenesis Inhibitors Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.4 China Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Angiogenesis Inhibitors Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 China Angiogenesis Inhibitors Market Revenues & Volume, By Inlyta, 2021- 2031F |
6.3.3 China Angiogenesis Inhibitors Market Revenues & Volume, By Avastin, 2021- 2031F |
6.3.4 China Angiogenesis Inhibitors Market Revenues & Volume, By Revlimid, 2021- 2031F |
6.3.5 China Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Angiogenesis Inhibitors Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 China Angiogenesis Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 China Angiogenesis Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 China Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Angiogenesis Inhibitors Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 China Angiogenesis Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 China Angiogenesis Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 China Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.6 China Angiogenesis Inhibitors Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 China Angiogenesis Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 China Angiogenesis Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 China Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
7 China Angiogenesis Inhibitors Market Import-Export Trade Statistics |
7.1 China Angiogenesis Inhibitors Market Export to Major Countries |
7.2 China Angiogenesis Inhibitors Market Imports from Major Countries |
8 China Angiogenesis Inhibitors Market Key Performance Indicators |
8.1 Number of clinical trials for angiogenesis inhibitors in China |
8.2 Adoption rate of angiogenesis inhibitors in major hospitals |
8.3 Investment in research and development of new angiogenesis inhibitors |
9 China Angiogenesis Inhibitors Market - Opportunity Assessment |
9.1 China Angiogenesis Inhibitors Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 China Angiogenesis Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 China Angiogenesis Inhibitors Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 China Angiogenesis Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 China Angiogenesis Inhibitors Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 China Angiogenesis Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Angiogenesis Inhibitors Market - Competitive Landscape |
10.1 China Angiogenesis Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 China Angiogenesis Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here